E
Scinai Immunotherapeutics Ltd. SCNI
$2.40 -$0.1134-4.51% NASDAQ
Recommendation
Prev Close
$2.51
Volume
699
Avg Vol (90D)
13,889
Market Cap
$2.35M
Dividend & Yield
--
52-Week Range
$1.90 - $8.92
P/E (TTM)
0.00
EPS (TTM)
-$79,464.80
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Short Interest Update
4/18/2025 - Ticker Report
Scinai Immunotherapeutics to Acquire Pincell for Novel Skin Disorder Treatment
3/27/2025 - TipRanks Financial Blog
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
3/27/2025 - PR Newswire
Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025
3/17/2025 - PR Newswire
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
3/5/2025 - GuruFocus
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
3/5/2025 - SeekingAlpha.com: All News
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
3/5/2025 - Seeking Alpha - Healthcare
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
3/5/2025 - Seeking Alpha - Israel Stocks
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
3/5/2025 - The Fly
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
3/5/2025 - PR Newswire
Scinai Immunotherapeutics files to sell 3.02M ADS for holders
3/4/2025 - The Fly
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Short Interest Update
3/1/2025 - Ticker Report
Analyzing Scinai Immunotherapeutics (NASDAQ:SCNI) and bluebird bio (NASDAQ:BLUE)
1/8/2025 - Ticker Report
Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences
1/6/2025 - PR Newswire
SABBY MANAGEMENT, LLC Acquires Shares in Scinai Immunotherapeutics Ltd
1/4/2025 - GuruFocus
Financial Survey: Scinai Immunotherapeutics (NASDAQ:SCNI) and#038; Adaptimmune Therapeutics (NASDAQ:ADAP)
12/20/2024 - Ticker Report
Scinai Immunotherapeutics Establishes U.S. ...
12/16/2024 - GuruFocus
Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.
12/16/2024 - PR Newswire
Prof. Michael Schn, Director of Dermatology and Venereology at the University Medical Center Gttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board
12/5/2024 - PR Newswire
Why Scinai Immunotherapeutics' (NASDAQ:SCNI) Healthy Earnings Aren't As Good As They Seem
11/29/2024 - Simply Wall St
Dr. Jonathan Sadeh, Former Senior Vice President of Immunology RandD at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board
11/27/2024 - PR Newswire
Scinai Immunotherapeutics Reports Financial Turnaround and Growth
11/25/2024 - TipRanks Financial Blog
Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million
11/22/2024 - PR Newswire
ARMISTICE CAPITAL, LLC Acquires New Stake in Scinai Immunotherapeutics Ltd
11/15/2024 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$14.85M
Total Debt (Q)
$20.82M
Total Liabilities (Q)
$22.14M
Book Value Per Share (Q)
-$34.80K
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, September 9, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
1.53
7-Day Total Return
25.01%
30-Day Total Return
-28.25%
60-Day Total Return
-31.82%
90-Day Total Return
-29.82%
Year to Date Total Return
-30.23%
1-Year Total Return
-47.58%
2-Year Total Return
-87.10%
3-Year Total Return
-98.14%
5-Year Total Return
-99.74%
52-week Low
Apr 15, 2025 - $1.90
52-week High
Jul 15, 2024 - $8.92
Valuation
Market Cap
$2.35M - Nano Cap
Enterprise Value
$2.54M
Price/Sales (TTM)
0.00
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
100.00
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.scinai.com
Phone Number
972 8 930 2529
Address
Jerusalem BioPark
2nd floor - Hadassah Ein Kerem Campus
Jerusalem,
Country
Israel
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious... more
NASDAQ 04/28/2025 10:13AM Eastern Quotes delayed